The Application dimension of the E‑Beam Sterilization Technology market is organized around five principal end‑use categories. Medical devices dominate with an estimated 45 % share, driven by stringent regulatory mandates for aseptic processing of implants, catheters, and surgical tools; this segment fuels the highest revenue due to premium pricing and recurring sterilization cycles. Pharmaceuticals represent roughly 30 % of market volume, encompassing bulk drug substances, biologics, and sterile injectables where e‑beam offers rapid, residue‑free validation. Food & beverage accounts for about 15 %, primarily for ready‑to‑eat meals, spices, and packaging materials where microbial load reduction extends shelf life without thermal damage. Cosmetics & personal care contributes near 7 %, targeting creams, lotions, and packaging that require non‑thermal sterility to preserve active ingredients. The residual 3 % classified as Others includes aerospace components, polymer films, and research‑grade materials. Collectively, these application sub‑segments define the overall market size and are reflected in the accompanying pie‑chart, illustrating the relative weight of each category in the E‑Beam Sterilization Technology segmentation.